Acerta Pharma, an affiliate of AstraZeneca, is a pioneering biopharmaceutical company based in Redwood City, CA. With a focus on haematology, they are dedicated to pushing the boundaries of scientific innovation to redefine care for patients with blood cancers. Leveraging their scientific platforms, Acerta Pharma develops and tests novel investigational agents that directly target and eliminate cancer cells or harness the immune system to combat cancer. Their commitment to addressing high unmet needs in blood cancers drives their pipeline of first-in-class and best-in-class medicines. Working closely with AstraZeneca, Acerta Pharma takes an innovative approach to drug discovery, utilizing cutting-edge technologies and multi-omic platforms to understand the complex biology of hematological malignancies. Their research and development center in the Netherlands, located at the Pivot Park Biotechnology Campus, is equipped with core capabilities in target identification, validation, lead generation, and compound optimization. Through collaborative efforts, Acerta Pharma and AstraZeneca are dedicated to advancing innovative clinical strategies and combining their extensive oncology portfolio to provide transformative therapies for patients.Generated from the website